Ondansetron Hydrochloride
Product Images NDC 67296-0902

2 FDA label images from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 67296-0902). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 Count (67296 0902 2)

20 Count (67296 0902 2)
Label for Ondansetron Hydrochloride 4 mg tablets, containing 20 tablets. The label states prescription use only with lot number 20010AX1 and expiration date 06/24. Manufactured by Aurobindo Pharma Ltd in Hyderabad, India, distributed by RedPharm Drug, Inc., Eden Prairie, MN.*
FDA Label Image

Ondansetron 4mg (Doc20170421104200 001)

Ondansetron 4mg (Doc20170421104200 001)
Packaging label for Ondansetron Hydrochloride 4 mg tablets, showing a package containing 3 tablets. The label includes the NDC number 67296-0902, and states Rx Only. Manufacturer is Aurobindo Pharma Limited, while the labeler is RedPharm Drug, Inc. The label also shows storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.